ClinicalTrials.govpublic full text
A Multi-Center, Open-Label Study of Fruquintinib in Solid Tumors and Colorectal, and Breast Cancers
advanced solid tumors, metastatic colon cancer, metastatic breast cancer, triple negative breast cancer, her2-negative breast cancer, hormone receptor positive breast carcinoma, rectal cancer, vegf, colorectal, breast, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 838092
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.